These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 18157836

  • 21. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
    Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK, Bhanot S, Monia BP, Li YX, Diehl AM.
    Hepatology; 2007 Jun; 45(6):1366-74. PubMed ID: 17476695
    [Abstract] [Full Text] [Related]

  • 22. NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis.
    Dela Peña A, Leclercq I, Field J, George J, Jones B, Farrell G.
    Gastroenterology; 2005 Nov; 129(5):1663-74. PubMed ID: 16285964
    [Abstract] [Full Text] [Related]

  • 23. Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice.
    Ip E, Farrell G, Hall P, Robertson G, Leclercq I.
    Hepatology; 2004 May; 39(5):1286-96. PubMed ID: 15122757
    [Abstract] [Full Text] [Related]

  • 24. Lipid metabolism, oxidative stress and cell death are regulated by PKC delta in a dietary model of nonalcoholic steatohepatitis.
    Greene MW, Burrington CM, Lynch DT, Davenport SK, Johnson AK, Horsman MJ, Chowdhry S, Zhang J, Sparks JD, Tirrell PC.
    PLoS One; 2014 May; 9(1):e85848. PubMed ID: 24454937
    [Abstract] [Full Text] [Related]

  • 25. Adenosine A(2a) receptor stimulation prevents hepatocyte lipotoxicity and non-alcoholic steatohepatitis (NASH) in rats.
    Imarisio C, Alchera E, Sutti S, Valente G, Boccafoschi F, Albano E, Carini R.
    Clin Sci (Lond); 2012 Sep; 123(5):323-32. PubMed ID: 22439844
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model.
    Sahai A, Malladi P, Melin-Aldana H, Green RM, Whitington PF.
    Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G264-73. PubMed ID: 15044174
    [Abstract] [Full Text] [Related]

  • 34. Bile acids override steatosis in farnesoid X receptor deficient mice in a model of non-alcoholic steatohepatitis.
    Wu W, Liu X, Peng X, Xue R, Ji L, Shen X, Chen S, Gu J, Zhang S.
    Biochem Biophys Res Commun; 2014 May 23; 448(1):50-5. PubMed ID: 24747563
    [Abstract] [Full Text] [Related]

  • 35. Aldose reductase is involved in the development of murine diet-induced nonalcoholic steatohepatitis.
    Qiu L, Lin J, Ying M, Chen W, Yang J, Deng T, Chen J, Shi D, Yang JY.
    PLoS One; 2013 May 23; 8(9):e73591. PubMed ID: 24066058
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Silibinin ameliorates hepatic lipid accumulation and oxidative stress in mice with non-alcoholic steatohepatitis by regulating CFLAR-JNK pathway.
    Liu Y, Xu W, Zhai T, You J, Chen Y.
    Acta Pharm Sin B; 2019 Jul 23; 9(4):745-757. PubMed ID: 31384535
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.